Structural Basis for the Inhibition of RNase H Activity of HIV-1 Reverse Transcriptase by RNase H Active Site-Directed Inhibitors

HIV/AIDS continues to be a menace to public health. Several drugs currently on the market have successfully improved the ability to manage the viral burden in infected patients. However, new drugs are needed to combat the rapid emergence of mutated forms of the virus that are resistant to existing t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Su, Hua-Poo, Yan, Youwei, Prasad, G. Sridhar, Smith, Robert F., Daniels, Christopher L., Abeywickrema, Pravien D., Reid, John C., Loughran, H. Marie, Kornienko, Maria, Sharma, Sujata, Grobler, Jay A., Xu, Bei, Sardana, Vinod, Allison, Timothy J., Williams, Peter D., Darke, Paul L., Hazuda, Daria J., Munshi, Sanjeev
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2010
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2897604/
https://ncbi.nlm.nih.gov/pubmed/20484498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00353-10
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars